Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chubb
Harvard Business School
Federal Trade Commission
Moodys
Accenture

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 7,777,058

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,777,058
Title:Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof
Abstract: In the present invention there are disclosed new derivatives of dianhydrohexite mononitrate corresponding to formula (I), tautomers, pharmaceutically acceptable salts, prodrugs and solvates thereof: ##STR00001## as well as pharmaceutical compositions comprising these compounds and uses thereof.
Inventor(s): Moliner; Jose Repolles (Barcelona, ES), Perez-Rasilla; Eduardo Salas (Barcelona, ES), Coy; Francisco Pubill (Barcelona, ES)
Assignee: Lacer S.A. (Barcelona, ES)
Application Number:12/400,394
Patent Claims:see list of patent claims

Details for Patent 7,777,058

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech ACTIVASE alteplase VIAL; SINGLE-USE 103172 001 1987-11-13 ➤ Sign Up Lacer S.A. (Barcelona, ES) 2036-04-30 RX search
Genentech ACTIVASE alteplase VIAL; SINGLE-USE 103172 002 1987-11-13 ➤ Sign Up Lacer S.A. (Barcelona, ES) 2036-04-30 RX search
Genentech CATHFLO ACTIVASE alteplase VIAL 103172 003 1987-11-13 ➤ Sign Up Lacer S.A. (Barcelona, ES) 2036-04-30 RX search
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22 ➤ Sign Up Lacer S.A. (Barcelona, ES) 2036-04-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
Citi
US Army
Argus Health
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.